First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
20.05
+1.95 (10.77%)
At close: Apr 28, 2026, 4:00 PM EDT
19.56
-0.49 (-2.44%)
After-hours: Apr 28, 2026, 7:58 PM EDT

TRAX Statistics

Total Valuation

TRAX has a market cap or net worth of $696.71 million. The enterprise value is $399.19 million.

Market Cap 696.71M
Enterprise Value 399.19M

Important Dates

The next estimated earnings date is Monday, June 1, 2026.

Earnings Date Jun 1, 2026
Ex-Dividend Date n/a

Share Statistics

TRAX has 34.75 million shares outstanding.

Current Share Class 34.75M
Shares Outstanding 34.75M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 1.83%
Owned by Institutions (%) n/a
Float 30.94M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.42
P/TBV Ratio 2.42
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.20, with a Debt / Equity ratio of 0.05.

Current Ratio 10.20
Quick Ratio 10.05
Debt / Equity 0.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -48.91% and return on invested capital (ROIC) is -31.55%.

Return on Equity (ROE) -48.91%
Return on Assets (ROA) -28.97%
Return on Invested Capital (ROIC) -31.55%
Return on Capital Employed (ROCE) -59.76%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$1.60M
Employee Count 104
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 52.89
Average Volume (20 Days) 307,959

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit -139.61M
Operating Income -179.01M
Pretax Income -166.09M
Net Income -166.09M
EBITDA -178.45M
EBIT -179.01M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has $311.64 million in cash and $14.11 million in debt, giving a net cash position of $297.53 million or $8.56 per share.

Cash & Cash Equivalents 311.64M
Total Debt 14.11M
Net Cash 297.53M
Net Cash Per Share $8.56
Equity (Book Value) 287.49M
Book Value Per Share n/a
Working Capital 285.38M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$142.93 million and capital expenditures -$87,000, giving a free cash flow of -$143.01 million.

Operating Cash Flow -142.93M
Capital Expenditures -87,000
Depreciation & Amortization 559,000
Net Borrowing n/a
Free Cash Flow -143.01M
FCF Per Share -$4.12
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TRAX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -23.84%
FCF Yield -20.53%

Analyst Forecast

The average price target for TRAX is $38.40, which is 91.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target $38.40
Price Target Difference 91.52%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1